Epidemiological and Clinical Profile of Deaths due to COVID-19 among Hospitalized Patients in Sidama Region, Ethiopia
Table 5. Summary of adverse events ofmechanical ventilation and survival time among COVID-19 related deaths
| Variables | Mechanical ventilation (n=111) | Survival time (n=186) | ||||
| Yes | No | p-value | Yes | No | p-value | |
| Age group |
|
|
|
|
|
|
| 18-39 | 18(94.7%) | 1(5.3%) | 0.46 | 25(75.8%) | 8(24.2%) | 0.006 |
| 40-60 | 44(93.6%) | 3(6.4%) |
| 34(50.7%) | 33(49.3%) |
|
| ≥61 | 49(87.5%) | 7(12.5%) |
| 63(73.3%) | 23(26.7%) |
|
| Sex |
|
|
|
|
|
|
| Male | 78(89.7%) | 9(10.3%) | 0.509f | 86(63.7%) | 49(36.3%) | 0.489 |
| Female | 33(94.3%) | 2(5.7%) |
| 36(70.6%) | 15(29.4%) |
|
| Comorbidity |
|
|
|
|
|
|
| Yes | 74(87.1%) | 11(22.9%) | 0.033f | 77(64.2%) | 43(35.8%) | 0.631 |
| No | 37(100%) | 0 |
| 45(68.2%) | 21(31.8%) |
|
| Number of comorbidity |
|
|
|
|
|
|
| One | 50(92.6%) | 4(7.4%) | 0.089f | 50(64.9%) | 27(35.1%) | 0.814 |
| Two or more | 24(77.4%) | 7(22.6%) |
| 27(62.8%) | 16(37.8%) |
|
| Type of comorbidity |
|
|
|
|
|
|
| Diabetes | 40(85.1%) | 7(14.9%) | 0.747f | 39(65%) | 21(35%) | 0.849 |
| Hypertension | 29(85.3%) | 5(14.7%) | 0.748f | 33(70.2%) | 14(29.8%) | 0.268 |
| HIV/AIDS | 2(66.7%) | 1(33.3%) | 0.344f | 4(57.1%) | 3(42.9%) | 0.7 |
| Cancer | 1 | 0 | 1.00 | 3(60%) | 2(40%) | 1.00 |
| Asthma | 6(85.7%) | 1(14.3%) | 1.00 | 4(50%) | 4(50%) | 0.455 |
| Renal disease | 7(77.8%) | 2(22.2%) | 0.329f | 11(78.6%) | 3(21.4%) | 0.232 |
| Stroke | 2(66.7%) | 1(33.3%) | 0.344 | 4 | 0 | 0.295 |
| Cardiac disease | 7(77.8%) | 2(22.2%) | 0.329f | 7(53.8%) | 6(46.2%) | 0.541 |
f; fisher exact test